GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bonus BioGroup Ltd (OTCPK:BBIXF) » Definitions » Buyback Yield %

BBIXF (Bonus BioGroup) Buyback Yield % : 0.00 (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bonus BioGroup Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Bonus BioGroup's current buyback yield was 0.00%.


Bonus BioGroup Buyback Yield % Historical Data

The historical data trend for Bonus BioGroup's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonus BioGroup Buyback Yield % Chart

Bonus BioGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.42 -10.08 -7.16 -1.59 -

Bonus BioGroup Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bonus BioGroup's Buyback Yield %

For the Biotechnology subindustry, Bonus BioGroup's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonus BioGroup's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bonus BioGroup's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Bonus BioGroup's Buyback Yield % falls into.



Bonus BioGroup Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Bonus BioGroup's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 23.3586
=0.00%

Bonus BioGroup's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 24.458
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2024) data.


Bonus BioGroup Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Bonus BioGroup's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonus BioGroup Business Description

Traded in Other Exchanges
Address
Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is a biotechnology company. It generates viable tissue-regenerating bone grafts. The company treats skeletal disorders such as bone- and cartilage-related arthritis and various types of bone and joint trauma. It is in the field of tissue engineering, human adipose tissue-derived cells and live bone transplantation.

Bonus BioGroup Headlines